<i>Evaluating the Efficacy of Microcurrent Infusion Technology in Enhancing Thyroid Function and Alleviating Symptoms in Hypothyroid Patients: A Pilot Study Using the eMedica Device</i>

A cross-sectional analysis was conducted with 30 patients diagnosed with hypothyroidism and on stable levothyroxine dosages. Participants underwent 30-minute sessions of microcurrent therapy targeting the thyroid region using the eMedica device for a total of eight weeks every day. Serum levels of TSH was measured pre- and post-intervention. Symptom severity was assessed using a validated hypothyroid symptom scoring system. Data were analyzed using paired t-tests to evaluate the significance of changes in biochemical and symptomatic outcomes.本研究针对30名确诊为甲状腺功能减退症且左甲状腺素（levothyroxine）服用剂量稳定的患者开展横断面分析（cross-sectional analysis）。受试者每日接受以eMedica设备针对甲状腺区域实施的30分钟微电流疗法（microcurrent therapy），每日干预，总计持续8周。于干预前后检测受试者血清促甲状腺激素（Thyroid-Stimulating Hormone, TSH）水平；采用经过验证的甲状腺功能减退症状评分量表对症状严重程度进行评估。本研究采用配对t检验（paired t-tests）分析实验数据，以评估生化指标与症状学结局变化的统计学显著性。